BerGenBio ASA (BGBIO.OL)

NOK 8.72

(-2.83%)

Total Assets Summary of BerGenBio ASA

  • BerGenBio ASA's latest annual total assets in 2023 was 174.33 Million NOK , up 4.58% from previous year.
  • BerGenBio ASA's latest quarterly total assets in 2024 Q2 was 218.47 Million NOK , up 61.31% from previous quarter.
  • BerGenBio ASA reported annual total assets of 166.7 Million NOK in 2022, down -62.97% from previous year.
  • BerGenBio ASA reported annual total assets of 450.23 Million NOK in 2021, down -39.01% from previous year.
  • BerGenBio ASA reported quarterly total assets of 218.47 Million NOK for 2024 Q2, up 61.31% from previous quarter.
  • BerGenBio ASA reported quarterly total assets of 174.33 Million NOK for 2023 FY, up 4.58% from previous quarter.

Annual Total Assets Chart of BerGenBio ASA (2023 - 2014)

Historical Annual Total Assets of BerGenBio ASA (2023 - 2014)

Year Total Assets Total Assets Growth
2023 174.33 Million NOK 4.58%
2022 166.7 Million NOK -62.97%
2021 450.23 Million NOK -39.01%
2020 738.2 Million NOK 173.03%
2019 270.37 Million NOK -28.63%
2018 378.82 Million NOK -1.43%
2017 384.33 Million NOK 120.2%
2016 174.53 Million NOK 111.84%
2015 82.39 Million NOK -32.25%
2014 121.6 Million NOK 0.0%

Peer Total Assets Comparison of BerGenBio ASA

Name Total Assets Total Assets Difference
Arctic Bioscience AS 300.25 Million NOK 41.937%
Aqua Bio Technology ASA 34.42 Million NOK -406.354%
ArcticZymes Technologies ASA 339.32 Million NOK 48.623%
Hofseth BioCare ASA 390.11 Million NOK 55.312%
PCI Biotech Holding ASA 44.05 Million NOK -295.766%
Thor Medical ASA 330.83 Million NOK 47.305%
Ultimovacs ASA 349.03 Million NOK 50.053%